OM1
Boston, US · Delaware corporation · 5 known investors
OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data. The platform serves healthcare systems, pharmaceutical companies, and research organizations seeking to close evidence gaps and improve clinical decision-making.
Founders & leadership
RG

Richard Gliklich, MDFounder
GG
Gary GottliebDirector
LB
Larry BohnDirector
DB
David BarrettDirector
RE
Richard E. GliklichExecutive Officer, Director
RO
Rory O'DriscollDirector
Investors · 5
Competitors · 6
by search overlapDiabetes Prevention Program43 shared keywords
ResearchGate19 shared keywords
Carbon Health10 shared keywords
H19 shared keywordsH1 operates an AI-driven platform that integrates healthcare data to identify and match doctors for clinical trials, patient care, medical affairs, and referrals. The company serves pharmaceutical companies, healthcare providers, and other organizations that need to connect with appropriate medical expertise.
Cowles_Investments_StemCentrx8 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.
Ziprecruiter8 shared keywords
Companies competing with OM1 for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$85MraisedJul 2021 · 10 investors · Other TechnologyRule 506(b)
▶$85MraisedJul 2021 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rory O'DriscollDirector
- Gary GottliebDirector
- Larry BohnDirector
- David BarrettDirector
- Richard E. GliklichExecutive Officer, Director
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- OM1 Raises $85M in Funding - FinSMEsfinsmes.com · 2021
- OM1's real-world evidence analytics banks $50M Series C | MobiHealthNewsmobihealthnews.com · 2019
- Real-World Outcomes & Technology Company OM1 Closes $50 Million Series C Financing To Make Healthcare More Measured, Precise, And Pre-Emptiveprnewswire.com · 2019
- OM1 Raises $15M to Expand Healthcare Outcome Analytics Platform - HIT Consultanthitconsultant.net · 2017